|
|
|||
| |||||||||||||||||||||||||||||||||||
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.
A healthy 33-year-old woman who works in an office calls to ask whether she should receive influenza vaccine. How should this patient be advised?
The Clinical Problem
Vaccination against influenzavirus is the primary strategy to reduce the morbidity and mortality associated with influenza. Because the benefit of vaccination is greatest for persons at increased risk for severe influenza and its complications as a result of
Background
Rates of Vaccination
Strategies and Evidence
Benefits of Vaccination in Healthy Adults
Cost of Vaccination
Adverse Effects of Vaccination
Use of Antiviral Drugs
Areas of Uncertainty
Guidelines
Conclusions and Recommendations
Source Information
From the Epidemiology Program Office (F.A., A.L.F.) and the National Immunization Program (J.A.S.), Centers for Disease Control and Prevention, Atlanta.
Address reprint requests to Dr. Ahmed at the Division of Prevention Research and Analytic Methods, Epidemiology Program Office, Centers for Disease Control and Prevention, MS-K73, 4770 Buford Hwy., Atlanta, GA 30341, or at fahmed@cdc.gov.
References
This article has been cited by other articles:
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved. |